Last 4,270 KRW
Change Today +15.00 / 0.35%
Volume 2.7K
014570 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 8:16 PM 09/1/14 All times are local (Market data is delayed by at least 15 minutes).

korean drug co ltd (014570) Snapshot

Open
4,255
Previous Close
4,255
Day High
4,295
Day Low
4,235
52 Week High
02/4/14 - 5,730
52 Week Low
09/2/13 - 2,780
Market Cap
47.0B
Average Volume 10 Days
78.3K
EPS TTM
70.00
Shares Outstanding
11.0M
EX-Date
12/27/13
P/E TM
61.0x
Dividend
60.00
Dividend Yield
1.41%
Current Stock Chart for KOREAN DRUG CO LTD (014570)

Related News

No related news articles were found.

korean drug co ltd (014570) Related Businessweek News

No Related Businessweek News Found

korean drug co ltd (014570) Details

Korean Drug Co., Ltd. discovers, develops, manufactures, and markets medicines for treating human illness in South Korea. It offers over the counter and ETC medicines in various categories, including anti ulcer agents, remedies for respiratory diseases and cold, topical agents for dermatoses, antibiotics and chemotherapuetics, hypnotics, antihistaminics, anti fungal agents, amino acids nutrients, multivitamins and minerals, nootropics, antipyretics, and home pregnancy test kits. The company also provides health food. Korean Drug Co., Ltd. was founded in 1980 and is based in Seoul, South Korea.

Founded in 1980

korean drug co ltd (014570) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

korean drug co ltd (014570) Key Developments

Korean Drug Co. Ltd., Annual General Meeting, Mar 22, 2013

Korean Drug Co. Ltd., Annual General Meeting, Mar 22, 2013., at 10:00 Korea Standard Time. Location: Icheon, Gyeonggi-ri 3000 to 50 seram Savings Bank 5th Floor,. Agenda: To consider financial position, statement of comprehensive income and statement of appropriation of the surplus profits approval; to consider Incorporation of some changes; to consider Election of Directors; to consider audit appointment ; to consider approval of directors' remuneration limit; to consider the approval of the audit fees limit; and to consider other references concerning investment decisions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
014570:KS 4,270.00 KRW +15.00

014570 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 014570.
View Industry Companies
 

Industry Analysis

014570

Industry Average

Valuation 014570 Industry Range
Price/Earnings 46.4x
Price/Sales 1.1x
Price/Book 1.0x
Price/Cash Flow 35.9x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KOREAN DRUG CO LTD, please visit www.nicepharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.